ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,258.30
-0.92%
Dow Jones
39,051.83
-1.56%
US Dollar vs MXN
16.74699
0.49%
Brent Oil
81.095
-0.53%
Bitcoin
67,309.93
-2.59%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Foamix Pharmaceuticals Ltd (FOMX)

  7. Foamix Pharmaceuticals Ltd (FOMX) Noticias

FOMX

Foamix Pharmaceuticals (FOMX)

Foamix Pharmaceuticals Ltd
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:FOMX
FechaHoraFuenteTítuloSímboloCompañía
23/03/202005:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
19/03/202014:10Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
18/03/202015:34Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
18/03/202015:31Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
18/03/202008:53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
12/03/202006:17Edgar (US Regulatory)Annual Report (10-k)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
12/03/202006:03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
09/03/202008:27Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:FOMXFoamix Pharmaceuticals Ltd
03/03/202016:02Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
14/02/202016:46Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
28/01/202015:01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
07/01/202015:51Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
12/11/201916:09PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Foamix Pharmaceuticals Ltd.NASDAQ:FOMXFoamix Pharmaceuticals Ltd
12/11/201905:18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
19/08/201915:37Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
15/08/201916:11Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
06/08/201916:12Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
18/04/201915:25Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
11/03/201905:03Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
08/03/201907:44Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
01/03/201916:04Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
14/09/201815:22Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
02/04/201815:07Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
01/03/201815:31Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
28/11/201715:06Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
14/09/201706:00PR Newswire (US)OWC Pharma Issues Chairman's Letter to ShareholdersNASDAQ:FOMXFoamix Pharmaceuticals Ltd
24/02/201715:07Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
21/02/201715:09Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
12/09/201615:02Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3/a)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
09/03/201618:46GlobeNewswire Inc.Foamix to Present Corporate Overview at the 36th Annual Cowen & Company Healthcare ConferenceNASDAQ:FOMXFoamix Pharmaceuticals Ltd
 Showing the most relevant articles for your search:NASDAQ:FOMX

Su Consulta Reciente

USOTC
XYIGF
Xinyi Glass (PK)
BIT
P1WUB1
NLBNPIT1WUB1 20240918 4600
NASDAQ
RCPRX
RBC BlueBay Core Plus Bo...
BITMOT
833338
Comp Gobain Tf 1,125% Mz...
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados